Ron Yamamoto
Company: Oxular Ltd.
Job title: Chief Scientific Officer
Seminars:
Panel Discussion: Overcoming Challenges in Suprachoroidal Drug Delivery to Streamline Clinical Development 12:00 pm
day: Conference Day One
Workshop A – Expanding the Potential of the Suprachoroidal Space in Retinal Therapy 9:00 am
Key Topics to be discussed: Overview of the current landscape of suprachoroidal delivery, and available technologies Non-clinical distribution and AAV expression achieved with Everads’ SCS injector Clinical experience from Everads’ ongoing clinical trial Use of thermal imaging for confirmation of suprachoroidal deliveryRead more
day: Pre-Conference Workshop Day